Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography (ATAC)

This study is currently recruiting participants.
Verified December 2012 by The Cleveland Clinic
Sponsor:
Information provided by (Responsible Party):
Sunil Srivastava, The Cleveland Clinic
ClinicalTrials.gov Identifier:
NCT01746537
First received: December 7, 2012
Last updated: December 10, 2012
Last verified: December 2012
  Purpose

A prospective, observational, case series investigating the feasibility of utilizing OCT scans of the anterior chamber of eyes with uveitis.


Condition
Uveitis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Automated Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography

Resource links provided by NLM:


Further study details as provided by The Cleveland Clinic:

Primary Outcome Measures:
  • Use the OCT to objectively image and grade the degree of anterior chamber inflammation in eyes with inactive and active uveitis. [ Time Frame: one year ] [ Designated as safety issue: No ]

Estimated Enrollment: 250
Study Start Date: June 2012
Estimated Study Completion Date: June 2014
Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Patients with inactive and active uveitis.

Criteria

Inclusion Criteria:

  • All patients presenting to Cole Eye Institute with uveitis.

Exclusion Criteria:

  • Inability to provide informed consent, including non-English speaking and cognitively/mentally impaired.
  • Severe corneal opacities preventing imaging of anterior chamber
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01746537

Contacts
Contact: Sunil K Srivastava, M.D. 216-636-2286
Contact: Kimberly M Baynes, study coordinator 216-44-2566

Locations
United States, Ohio
Cole Eye Institute Recruiting
Cleveland, Ohio, United States, 44195
Contact: Sunil K Srivastava, M.D.    216-636-2286      
Contact: Kimberly M Baynes, study coordinator    216-444-2566      
Principal Investigator: Sunil K Srivastava, M.D.         
Sponsors and Collaborators
The Cleveland Clinic
  More Information

No publications provided

Responsible Party: Sunil Srivastava, Medical Doctor, The Cleveland Clinic
ClinicalTrials.gov Identifier: NCT01746537     History of Changes
Other Study ID Numbers: 12-612
Study First Received: December 7, 2012
Last Updated: December 10, 2012
Health Authority: United States: Food and Drug Administration

Additional relevant MeSH terms:
Inflammation
Uveitis
Chorioretinitis
Pathologic Processes
Uveal Diseases
Eye Diseases
Retinitis
Retinal Diseases
Choroiditis
Choroid Diseases
Uveitis, Posterior
Panuveitis

ClinicalTrials.gov processed this record on April 22, 2014